188 related articles for article (PubMed ID: 37326257)
1. Recent advancements in glucose dysregulation and pharmacological management of osteoporosis in transfusion-dependent thalassemia (TDT): an update of ICET-A (International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescence Medicine).
Tzoulis P; Yavropoulou MP; Banchev A; Modeva I; Daar S; De Sanctis V
Acta Biomed; 2023 Jun; 94(3):e2023178. PubMed ID: 37326257
[TBL] [Abstract][Full Text] [Related]
2. The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network.
De Sanctis V; Soliman A; Tzoulis P; Daar S; Kattamis A; Delaporta P; Karimi M; Yassin MA; Zarei T; Saki F; Sapunarova K; Banchev A; Galati MC; Raiola G; Messina G; Campisi S; Kattamis C
Acta Biomed; 2022 May; 93(2):e2022162. PubMed ID: 35546014
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of endocrine complications in transfusion dependent thalassemia in Hospital Pulau Pinang: A pilot study.
Lee KT; Lim SL; Goh AS
Med J Malaysia; 2020 Jan; 75(1):33-37. PubMed ID: 32008017
[TBL] [Abstract][Full Text] [Related]
4. Iron burden and endocrine complications in transfusion-dependent thalassemia patients In Sarawak, Malaysia: a retrospective study.
Chow LC; Lee BS; Tang SO; Loh EW; Ng SC; Tan XY; Ahmad Noordin MN; Ong GB; Chew LC
Med J Malaysia; 2024 May; 79(3):281-287. PubMed ID: 38817060
[TBL] [Abstract][Full Text] [Related]
5. Glucose Metabolism and Insulin Response to Oral Glucose Tolerance Test (OGTT) in Prepubertal Patients with Transfusion-Dependent β-thalassemia (TDT): A Long-Term Retrospective Analysis.
De Sanctis V; Soliman AT; Tzoulis P; Daar S; Di Maio S; Fiscina B; Kattamis C
Mediterr J Hematol Infect Dis; 2021; 13(1):e2021051. PubMed ID: 34527203
[TBL] [Abstract][Full Text] [Related]
6. Selected highlights of the VIII International Symposium of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine (ICET-A) on Growth, Puberty and Endocrine Complications in Thalassaemia. Auditorium of the Sultan Qaboos University (SQU) Muscat (Sultanate of Oman), 20th of December 2014.
De Sanctis V; Soliman AT; Wali Y; Elsedfy H; Daar S; Al-Yaarubi SA; Mevada ST; Elshinawy M; Fawzy H; Al-Subhi T; Al-Rawas A; Al-Muslehi M; El Kholy M
Pediatr Endocrinol Rev; 2015 Mar; 12(3):313-22. PubMed ID: 25962210
[TBL] [Abstract][Full Text] [Related]
7. Marital status and paternity in patients with Transfusion- Dependent Thalassemia (TDT) and Non Transfusion-Dependent Thalassemia (NTDT): an ICET - A survey in different countries.
De Sanctis V; Soliman AT; El-Hakim I; Christou S; Mariannis D; Karimi M; Ladis V; Kattamis A; Daar S; Yassin M; Canatan D; Galati MC; Raiola G; Campisi S; Kakkar S; Kaleva V; Saki F; Ellinides A; Pikis G; Christodoulides C; Abdulla M; Di Maio S; Theodoridis C; Elsedfy H; Kattamis C
Acta Biomed; 2019 Sep; 90(3):225-237. PubMed ID: 31580308
[TBL] [Abstract][Full Text] [Related]
8. The effect of zinc deficiency and iron overload on endocrine and exocrine pancreatic function in children with transfusion-dependent thalassemia: a cross-sectional study.
Mousa SO; Abd Alsamia EM; Moness HM; Mohamed OG
BMC Pediatr; 2021 Oct; 21(1):468. PubMed ID: 34686155
[TBL] [Abstract][Full Text] [Related]
9. The clinical characteristics, biochemical parameters and insulin response to oral glucose tolerance test (OGTT) in 25 transfusion dependent β-thalassemia (TDT) patients recently diagnosed with diabetes mellitus (DM).
De Sanctis V; Soliman A; Tzoulis P; Daar S; Karimi M; Yassin MA; Pozzobon G; Kattamis C
Acta Biomed; 2022 Jan; 92(6):e2021488. PubMed ID: 35075059
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran.
Bordbar M; Bozorgi H; Saki F; Haghpanah S; Karimi M; Bazrafshan A; Zekavat OR
J Endocrinol Invest; 2019 Dec; 42(12):1467-1476. PubMed ID: 31228105
[TBL] [Abstract][Full Text] [Related]
11. Iron Chelation Therapy as a Modality of Management.
Aydinok Y
Hematol Oncol Clin North Am; 2018 Apr; 32(2):261-275. PubMed ID: 29458731
[TBL] [Abstract][Full Text] [Related]
12. Denosumab effects on serum levels of the bone morphogenetic proteins antagonist noggin in patients with transfusion-dependent thalassemia and osteoporosis.
Voskaridou E; Ntanasis-Stathopoulos I; Christoulas D; Sonnleitner L; Papaefstathiou A; Dimopoulou M; Missbichler A; Kanellias N; Repa K; Papatheodorou A; Peppa M; Hawa G; Terpos E
Hematology; 2019 Dec; 24(1):318-324. PubMed ID: 30665323
[TBL] [Abstract][Full Text] [Related]
13. Severe Liver Iron Concentrations (LIC) in 24 Patients with β-Thalassemia Major: Correlations with Serum Ferritin, Liver Enzymes and Endocrine Complications.
Kanbour I; Chandra P; Soliman A; De Sanctis V; Nashwan A; Abusamaan S; Moustafa A; Yassin MA
Mediterr J Hematol Infect Dis; 2018; 10(1):e2018062. PubMed ID: 30416694
[TBL] [Abstract][Full Text] [Related]
14. Systematic Literature Review of the Burden of Disease and Treatment for Transfusion-dependent β-Thalassemia.
Betts M; Flight PA; Paramore LC; Tian L; Milenković D; Sheth S
Clin Ther; 2020 Feb; 42(2):322-337.e2. PubMed ID: 31882227
[TBL] [Abstract][Full Text] [Related]
15. Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial.
Voskaridou E; Ntanasis-Stathopoulos I; Papaefstathiou A; Christoulas D; Dimopoulou M; Repa K; Papatheodorou A; Peppa M; Terpos E
Blood Adv; 2018 Nov; 2(21):2837-2847. PubMed ID: 30381400
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of growth and endocrine disorders in Malaysian children with transfusion-dependent thalassaemia.
Tan KA; Lum SH; Yahya A; Krishnan S; Jalaludin MY; Lee WS
Singapore Med J; 2019 Jun; 60(6):303-308. PubMed ID: 30556093
[TBL] [Abstract][Full Text] [Related]
17. A Multicenter ICET-A Study on Age at Menarche and Menstrual Cycles in Patients with Transfusion-Dependent Thalassemia (TDT) who Started Early Chelation Therapy with Different Chelating Agents.
Di Maio S; Marzuillo P; Daar S; Kattamis C; Karimi M; Forough S; Banchev A; Kaleva V; Christou S; Fortugno C; Delaporta P; Soliman AT; Tzoulis P; de Sanctis V
Mediterr J Hematol Infect Dis; 2023; 15(1):e2023058. PubMed ID: 38028391
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal study of ICET-A on glucose tolerance, insulin sensitivity and β-cell secretion in eleven β-thalassemia major patients with mild iron overload.
De Sanctis V; Soliman AT; Daar S; Tzoulis P; Di Maio S; Kattamis C
Acta Biomed; 2023 Feb; 94(1):e2023011. PubMed ID: 36786253
[TBL] [Abstract][Full Text] [Related]
19. Thalassemia.
Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
[TBL] [Abstract][Full Text] [Related]
20. Approach to the management of β thalassemia major associated osteoporosis - A long-standing relationship revisited.
Yavropoulou MP; Anastasilakis AD; Tzoulis P; Tournis S; Rigatou E; Kassi E; Kattamis A; Makras P
Acta Biomed; 2022 Oct; 93(5):e2022305. PubMed ID: 36300213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
